BHC Projected Dividend Yield

Bausch Health Companies Inc ( NYSE : BHC )

Bausch Health Companies Inc. is a global diversified pharmaceutical company. Co. develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the U.S. of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices.

30 YEAR PERFORMANCE RESULTS